Total Assets Summary of Alterity Therapeutics Limited

Alterity Therapeutics Limited's latest annual total assets in 2024 was 19.22 Million AUD , down -29.63% from previous year.
Alterity Therapeutics Limited's latest quarterly total assets in 2024 FY was 19.22 Million AUD , down -29.63% from previous quarter.
Alterity Therapeutics Limited reported annual total assets of 27.31 Million AUD in 2023, down -33.96% from previous year.
Alterity Therapeutics Limited reported annual total assets of 41.36 Million AUD in 2022, up 23.16% from previous year.
Alterity Therapeutics Limited reported quarterly total assets of 19.22 Million AUD for 2024 Q4, down 0.0% from previous quarter.
Alterity Therapeutics Limited reported quarterly total assets of 19.22 Million AUD for 2024 FY, down -29.63% from previous quarter.

Annual Total Assets Chart of Alterity Therapeutics Limited (2024 - 1998)

Historical Annual Total Assets of Alterity Therapeutics Limited (2024 - 1998)

Year	Total Assets	Total Assets Growth
2024	19.22 Million AUD	-29.63%
2023	27.31 Million AUD	-33.96%
2022	41.36 Million AUD	23.16%
2021	33.58 Million AUD	152.43%
2020	13.3 Million AUD	-33.17%
2019	19.9 Million AUD	6.32%
2018	18.72 Million AUD	-25.93%
2017	25.28 Million AUD	-25.04%
2016	33.72 Million AUD	-19.38%
2015	41.83 Million AUD	0.46%
2014	41.64 Million AUD	143.89%
2013	17.07 Million AUD	132.55%
2012	7.34 Million AUD	-18.52%
2011	9.01 Million AUD	32.49%
2010	6.8 Million AUD	47.95%
2009	4.59 Million AUD	-60.79%
2008	11.72 Million AUD	51.85%
2007	7.72 Million AUD	-25.96%
2006	10.42 Million AUD	-53.03%
2005	22.19 Million AUD	-46.07%
2004	41.16 Million AUD	151.9%
2003	16.34 Million AUD	-7.1%
2002	17.59 Million AUD	-21.07%
2001	22.28 Million AUD	6.76%
2000	20.87 Million AUD	1036.48%
1999	1.83 Million AUD	821.77%
1998	199.28 Thousand AUD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	22.19 Million AUD	0.0%
2024 Q4	19.22 Million AUD	0.0%
2024 FY	19.22 Million AUD	-29.63%
2023 FY	27.31 Million AUD	-33.96%
2023 Q4	27.31 Million AUD	0.0%
2023 Q2	33.38 Million AUD	0.0%
2022 Q2	44.93 Million AUD	0.0%
2022 FY	41.36 Million AUD	23.16%
2022 Q4	41.36 Million AUD	0.0%
2021 FY	33.58 Million AUD	152.43%
2021 Q4	33.58 Million AUD	0.0%
2021 Q2	37.4 Million AUD	0.0%
2020 Q2	14.48 Million AUD	0.0%
2020 Q3	9.9 Million AUD	-31.6%
2020 Q4	13.3 Million AUD	34.29%
2020 FY	13.3 Million AUD	-33.17%
2020 Q1	14.48 Million AUD	-27.24%
2019 Q1	14.14 Million AUD	-24.46%
2019 Q3	19.9 Million AUD	40.75%
2019 Q2	14.14 Million AUD	0.0%
2019 FY	19.9 Million AUD	6.32%
2019 Q4	19.9 Million AUD	0.0%
2018 Q3	18.72 Million AUD	-14.61%
2018 Q2	21.93 Million AUD	0.0%
2018 Q1	21.93 Million AUD	-13.25%
2018 FY	18.72 Million AUD	-25.93%
2018 Q4	18.72 Million AUD	0.0%
2017 Q1	30.41 Million AUD	-9.83%
2017 Q2	30.41 Million AUD	0.0%
2017 FY	25.28 Million AUD	-25.04%
2017 Q4	25.28 Million AUD	0.0%
2017 Q3	25.28 Million AUD	-16.87%
2016 Q3	33.72 Million AUD	-12.61%
2016 Q4	33.72 Million AUD	0.0%
2016 FY	33.72 Million AUD	-19.38%
2016 Q2	38.59 Million AUD	0.0%
2016 Q1	38.59 Million AUD	-7.75%
2015 Q2	39.8 Million AUD	0.0%
2015 Q3	41.83 Million AUD	5.1%
2015 FY	41.83 Million AUD	0.46%
2015 Q4	41.83 Million AUD	0.0%
2015 Q1	39.8 Million AUD	-4.41%
2014 Q3	41.64 Million AUD	69.8%
2014 Q2	24.52 Million AUD	0.0%
2014 Q4	41.64 Million AUD	0.0%
2014 FY	41.64 Million AUD	143.89%
2014 Q1	24.52 Million AUD	43.63%
2013 Q3	17.07 Million AUD	33.27%
2013 FY	17.07 Million AUD	132.55%
2013 Q4	17.07 Million AUD	0.0%
2013 Q2	12.81 Million AUD	0.0%
2013 Q1	12.81 Million AUD	74.5%
2012 FY	7.34 Million AUD	-18.52%
2012 Q4	7.34 Million AUD	0.0%
2012 Q2	7.58 Million AUD	0.0%
2011 Q2	3.65 Million AUD	0.0%
2011 FY	9.01 Million AUD	32.49%
2011 Q4	9.01 Million AUD	0.0%
2010 Q2	8.61 Million AUD	0.0%
2010 FY	6.8 Million AUD	47.95%
2010 Q4	6.8 Million AUD	0.0%
2009 Q4	4.59 Million AUD	0.0%
2009 FY	4.59 Million AUD	-60.79%
2009 Q2	8.3 Million AUD	0.0%
2008 Q2	9.82 Million AUD	0.0%
2008 Q4	11.72 Million AUD	0.0%
2008 FY	11.72 Million AUD	51.85%
2007 Q2	11.98 Million AUD	0.0%
2007 Q4	7.72 Million AUD	0.0%
2007 FY	7.72 Million AUD	-25.96%
2006 Q2	16.24 Million AUD	0.0%
2006 FY	10.42 Million AUD	-53.03%
2006 Q4	10.42 Million AUD	0.0%
2005 Q4	22.19 Million AUD	0.0%
2005 Q2	38.85 Million AUD	0.0%
2005 FY	22.19 Million AUD	-46.07%
2004 FY	41.16 Million AUD	151.9%
2004 Q4	41.16 Million AUD	0.0%
2004 Q2	18.25 Million AUD	0.0%
2003 Q4	16.34 Million AUD	0.0%
2003 FY	16.34 Million AUD	-7.1%
2003 Q2	14.88 Million AUD	0.0%
2002 FY	17.59 Million AUD	-21.07%
2001 FY	22.28 Million AUD	6.76%
2000 FY	20.87 Million AUD	1036.48%
1999 FY	1.83 Million AUD	821.77%
1998 FY	199.28 Thousand AUD	0.0%

Peer Total Assets Comparison of Alterity Therapeutics Limited

Name	Total Assets	Total Assets Difference
AdAlta Limited	5.57 Million AUD	-244.944%
Acrux Limited	8.96 Million AUD	-114.479%
Amplia Therapeutics Limited	14.84 Million AUD	-29.495%
Biome Australia Limited	8.27 Million AUD	-132.261%
BTC Health Limited	5.14 Million AUD	-273.363%
Chimeric Therapeutics Limited	15.27 Million AUD	-25.866%
CSL Limited	56.93 Billion AUD	99.966%
Clarity Pharmaceuticals Ltd	154.62 Million AUD	87.568%
Clinuvel Pharmaceuticals Limited	231.12 Million AUD	91.682%
Noxopharm Limited	6.78 Million AUD	-183.379%
PharmAust Limited	11.12 Million AUD	-72.8%
Proteomics International Laboratories Limited	10.87 Million AUD	-76.768%
Prescient Therapeutics Limited	20.39 Million AUD	5.733%
PYC Therapeutics Limited	91.23 Million AUD	78.93%
Race Oncology Limited	20.22 Million AUD	4.967%
Starpharma Holdings Limited	36.81 Million AUD	47.781%
EZZ Life Science Holdings Limited	25.55 Million AUD	24.766%
Botanix Pharmaceuticals Limited	112.46 Million AUD	82.907%
Memphasys Limited	12.43 Million AUD	-54.654%
Nyrada Inc.	5.9 Million AUD	-225.426%
Anatara Lifesciences Ltd	1.67 Million AUD	-1050.143%
Telix Pharmaceuticals Limited	398.3 Million AUD	95.174%
Bio-Gene Technology Limited	3.15 Million AUD	-508.425%
Zelira Therapeutics Limited	5.18 Million AUD	-270.87%
Patrys Limited	4.16 Million AUD	-361.934%
Dimerix Limited	32.07 Million AUD	40.073%
Neuren Pharmaceuticals Limited	247.97 Million AUD	92.248%
Orthocell Limited	26.61 Million AUD	27.772%
Imugene Limited	151.39 Million AUD	87.302%
Cynata Therapeutics Limited	8.38 Million AUD	-129.174%
Immutep Limited	147.44 Million AUD	86.962%
Arovella Therapeutics Limited	13.28 Million AUD	-44.706%
Nanollose Limited	241.95 Thousand AUD	-7845.304%
Invex Therapeutics Ltd	6.12 Million AUD	-214.111%
NeuroScientific Biopharmaceuticals Limited	5.43 Million AUD	-253.646%
Island Pharmaceuticals Limited	2.56 Million AUD	-649.618%
Biotron Limited	493.47 Thousand AUD	-3795.578%
Radiopharm Theranostics Limited	72.03 Million AUD	73.314%
Tissue Repair Ltd	19.38 Million AUD	0.855%
AnteoTech Limited	9.38 Million AUD	-104.918%
Hexima Limited	2.26 Million AUD	-747.233%
Paradigm Biopharmaceuticals Limited	27.39 Million AUD	29.816%
Recce Pharmaceuticals Ltd	6.36 Million AUD	-201.804%
Avecho Biotechnology Limited	7.31 Million AUD	-162.644%
Actinogen Medical Limited	21.31 Million AUD	9.798%
Immuron Limited	15.54 Million AUD	-23.626%
Argenica Therapeutics Limited	16.37 Million AUD	-17.379%

Global Stocks Search

Alterity Therapeutics Limited (ATH.AX)

Total Assets Summary of Alterity Therapeutics Limited

Annual Total Assets Chart of Alterity Therapeutics Limited (2024 - 1998)

Historical Annual Total Assets of Alterity Therapeutics Limited (2024 - 1998)

Peer Total Assets Comparison of Alterity Therapeutics Limited